Severe Wegener's granulomatosis successfully treated with rituximab
- Authors: Semenkova EN1,2, Krivosheyev OG1,2, Novikov PI1,2, Osipenko VI1,2, Nosova NR1,2, Parfenova SA1,2, Nikiforova NV1,2, Borodin OO1,2
-
Affiliations:
- I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care
- E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
- Issue: Vol 82, No 6 (2010)
- Pages: 53-55
- Section: Editorial
- Submitted: 09.04.2020
- Published: 15.06.2010
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30630
- ID: 30630
Cite item
Full Text
Abstract
About the authors
E N Semenkova
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
Кафедра терапии и профболезнейд-р мед. наук, проф; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
O G Krivosheyev
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
Кафедра терапии и профболезней; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
P I Novikov
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: novikov-pavel@mail.ru
Кафедра терапии и профболезнейаспирант; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
V I Osipenko
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
канд. мед. наук, зав., отд-ние лучевой диагностики, клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
N R Nosova
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
врач, клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
S A Parfenova
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
врач, клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
N V Nikiforova
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
зав., терапевтическое отд-ние, клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
O O Borodin
I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
Email: tareevka@mtu-net.ru
ординатор, клиника нефрологии, внутренних и профессиональных болезней им. Е. М. Тареева; ГОУ ВПО ММА им. И. М. Сеченова Росздрава; I. M. Sechenov Moscow Medical Academy, Russian Agency for Health Care; E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
References
- Клименко С. В., Семенкова Е. Н., Кривошеев О. Г. Применение человеческого иммуноглобулина в комплексном лечении гранулематоза Вегенера. Лечащий врач 2005; 4: 23-28.
- Reff M. E., Carner K., Chambers K. S. et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood 1994; 83: 435-445.
- Arzoo K., Sadeghi S., Liebman H. A. Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann. Rheum. Dis. 2002; 61: 922-924.
- Falk R. J., Jennette J. C. ANCA are pathogenic: oh yes they are! J. Am. Soc. Nephrol. 2002; 13: 1977-1979.
- Heeringa P., Tervaert J. W. Pathophysiology of ANCA-associated vasculitis: are ANCA really pathogenic? Kidney Int. 2004; 65: 1564-1567.
- Aouba A., Pagnoux C., Bienvenu B. et al. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects. Clin. Rev. Allergy Immunol. 2008; 34: 65-73.
- Jayne D. R., Burns S., Smith K. B-cell depletion with rituximab for refractory vasculitis. Kidney Blood Press. Res. 2003; 26: 294.
- Jones R. B., Ferraro A. J., Chaudhry A. N. et al. A multicenter survey of rituximab therapy for refractory antineurotrophil cytoplasmic antibody-associated vasculitis. Arthr. and Rheum. 2009; 60: 2156-2168.
- Keogh K. A., Wylam M. E., Stone J. H. et al. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthr. and Rheum. 2005; 52: 262-268.
- Lovric S., Erdbruegger U., Kümpers P. et al. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-center experience with 15 patients. Nephrol. Dial. Transplant. 2009; 24: 179-185.
- Martinez Del Pero M., Chaudhry A., Jones R. B. et al. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study. Clin. Otolaryngol. 2009; 34: 328-335.
- Eriksson P. Short-term outcome and safety in 5 patients with ANCA-positive vasculitis treated with rituximab. Kidney Blood Press. Res. 2003; 26: 294.
- Specks U., Fervenza F. C., McDonald T. J. et al. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthr. and Rheum. 2001; 44: 2836-2840.